Summary:
A PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO AND NSAID-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FASINUMAB IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP.
Qualified Participants Must:
• At least 18 years old
•
BMI less than 39
•
Clinical Diagnosis of Osteoarthritis on hip or knee
•
Moderate to severe pain on hip or knee
•
Currently on pain medication
Qualified Participants May Receive:
Free exams, free lab tests and free Xrays and MRI.